RETINAL DEGENERATION
Clinical trials for RETINAL DEGENERATION explained in plain language.
Never miss a new study
Get alerted when new RETINAL DEGENERATION trials appear
Sign up with your email to follow new studies for RETINAL DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Gene therapy injection aims to save sight in rare genetic disease
Disease control Not yet recruitingThis early-stage trial tests a single injection of AXV-101 gene therapy into one eye of 12 children and teens (ages 4-17) with Bardet-Biedl syndrome type 1, a rare genetic condition that causes progressive vision loss. The main goal is to see if the treatment is safe and tolerabl…
Matched conditions: RETINAL DEGENERATION
Phase: EARLY_PHASE1 • Sponsor: Axovia Therapeutics • Aim: Disease control
Last updated Jun 23, 2026 11:57 UTC
-
Magnetic pulses to the brain may bring back sight for the blind
Disease control Not yet recruitingThis study tests whether transcranial magnetic stimulation (TMS) can improve vision in adults aged 45-70 with severe retinal degeneration. Over 136 participants will receive either real TMS or a sham (fake) treatment for 5 days, then be followed for up to a year. The goal is to s…
Matched conditions: RETINAL DEGENERATION
Phase: NA • Sponsor: Shanghai High Myopia Study Group • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC